While there certainly have been strides in health, the workplace, governance, and education all over the world, so much still needs to be done to ensure that women’s needs are adequately addressed. Before the coronavirus outbreak, womenfolk have already been reeling under the force of stresses in various health areas.
In a bid to accelerate women’s empowerment in the area of health, Organon, a global healthcare company formed through a spinoff from Merck (Kenilworth, NJ, USA) has recently celebrated HER DAY, which marks the beginning of its mission to create a better and healthier every day for every woman.
“Our company is here to improve the health of women throughout their lives because we understand that women are at the foundation of a healthier world,” says Emman Tiglao, Organon Commercial Director in the Philippines.
Organon’s R&D philosophy is to build a business around patient needs, with the goal of identifying and advancing healthcare options for women that enable them to live their best lives every day.
“Organon’s mission is to change normalizing common female conditions. We believe this approach will be very successful – the ability to identify diseases earlier, the ability to modify the course of diseases or healthcare conditions and to ultimately, improve the quality of life for women at all stages,” Sandy Milligan, Head of Organon Research & Development shared.
In the Philippines, unintended pregnancies remain an important public health issue. Meanwhile, coronary heart disease along with other heart diseases, cancers, and diabetes are among the top ten leading cause of death among women in 2019.
The new healthcare company builds upon its strong foundation of more than 70 established and impactful medicines and solutions in a wide spectrum of concerns that include reproductive health, heart disease, breast cancer, allergies, and asthma.
